| 标题 |
511MO Third line rechallenge with cetuximab (Cet) and irinotecan in circulating tumor DNA (ctDNA) selected metastatic colorectal cancer (mCRC) patients: The randomized phase II CITRIC trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:C. S. Vivas; J. V. Barrull; C. F. Rodríguez; F. S. Ballabrera; V. Alonso-Orduña; et al 出版日期:2024-09-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)